JMP Securities Downgrades Intuitive Surgical (ISRG) to Market Underperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Wall Street ends down as US-Iran peace optimism fades
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Northland Securities Upgrades Intuitive Surgical (ISRG) to Market Perform
July 19, 2013 12:39 PM EDTNorthland Securities upgraded Intuitive Surgical (NASDAQ: ISRG) from Underperform to Market Perform with a price target of $370.00.
For an analyst ratings summary and ratings history on Intuitive Surgical click here. For more ratings... More
Cantor Fitzgerald Sticking By Intuitive Surgical (ISRG) Despite a 'Quarter to Forget'
July 19, 2013 10:01 AM EDTCantor Fitzgerald cut its price target on Intuitive Surgical (NASDAQ: ISRG) from $575 to $425 Friday, but maintained a Buy rating saying expectations have been properly reset.
To summarize, analyst Jermey Feffer commented: "Who knew that a slowdown in one procedure type could have such a... More
2-3 More Quarters of Pain for Intuitive Surgical (ISRG) - Goldman Sachs
July 19, 2013 8:42 AM EDTGoldman Sachs reiterated a Neutral rating and lowered its price target on Intuitive Surgical (NASDAQ: ISRG) from $500 to $410 following weak Q2 results and outlook after the close. The firm said new growth challenges are unlikely to bottom for 2-3 quarters.
Goldman analyst David Roman reduces... More
Intuitive Surgical, Inc. (ISRG) Misses Q2 EPS by 14c
July 18, 2013 4:21 PM EDTIntuitive Surgical, Inc. (NASDAQ: ISRG) reported Q2 EPS of $3.90, $0.14 worse than the analyst estimate of $4.04. Revenue for the quarter came in at $579 million versus the consensus estimate of $594.58 million.
NOTE: Company warned on July 8th
Intuitive Surgical ended the second quarter of... More
